-
2
-
-
84891944577
-
-
Substance Abuse and Mental Health Services Administration. HHS Publicatio (SMA) 13-4760, DAWN Series D-39. Rockville (MD): SAMHSA; Retrieved March 8, 2017
-
Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville (MD): SAMHSA; 2013. Available at: https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf. Retrieved March 8, 2017.
-
(2013)
Drug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits
-
-
-
3
-
-
84962424458
-
Relationship between nonmedical prescription-opioid use and heroin use
-
Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 2016;374:154–63.
-
(2016)
N Engl J Med
, vol.374
, pp. 154-163
-
-
Compton, WM1
Jones, CM2
Baldwin, GT.3
-
4
-
-
85118995666
-
NCHS data on drug-poisoning deaths
-
NCHS Factsheet. Retrieved March 8, 2017
-
National Center for Health Statistics. NCHS data on drug-poisoning deaths. NCHS Factsheet. Available at: https://www.cdc.gov/nchs/data/factsheets/factsheet_drug_poisoning.htm. Retrieved March 8, 2017.
-
-
-
-
5
-
-
84946405020
-
-
Bethesda (MD): NIDA; Retrieved March 8, 2017
-
National Institute on Drug Abuse. America’s addiction to opioids: heroin and prescription drug abuse. Bethesda (MD): NIDA; 2014. Available at: https://www.drugabuse.gov/about-nida/legislative-activities/testimonyto-congress/2016/americas-addiction-to-opioids-heroinprescription-drug-abuse. Retrieved March 8, 2017.
-
(2014)
America’s addiction to opioids: heroin and prescription drug abuse
-
-
-
6
-
-
84900441275
-
Increase in prescription opioid use during pregnancy among Medicaid-enrolled women
-
Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol 2014;123:997–1002.
-
(2014)
Obstet Gynecol
, vol.123
, pp. 997-1002
-
-
Desai, RJ1
Hernandez-Diaz, S2
Bateman, BT3
Huybrechts, KF.4
-
7
-
-
84860776122
-
Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009
-
Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307:1934–40.
-
(2012)
JAMA
, vol.307
, pp. 1934-1940
-
-
Patrick, SW1
Schumacher, RE2
Benneyworth, BD3
Krans, EE4
McAllister, JM5
Davis, MM.6
-
8
-
-
84938292107
-
Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 [published erratum appears in J Perinatol 2015;35:667]
-
Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 [published erratum appears in J Perinatol 2015;35:667]. J Perinatol 2015;35:650–5.
-
(2015)
J Perinatol
, vol.35
, pp. 650-655
-
-
Patrick, SW1
Davis, MM2
Lehmann, CU3
Cooper, WO.4
-
10
-
-
85061428196
-
-
Maryland Department of Health and Mental Hygiene. Baltimore (MD): DHMH; Retrieved March 8, 2017
-
Maryland Department of Health and Mental Hygiene. Maryland maternal mortality review 2016 annual report. Baltimore (MD): DHMH; 2016. Available at: http://healthymaryland.org/wp-content/uploads/2011/05/MMR_ Report_2016_clean-copy_FINAL.pdf. Retrieved March 8, 2017.
-
(2016)
Maryland maternal mortality review 2016 annual report
-
-
-
11
-
-
0034605531
-
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
-
McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689–95.
-
(2000)
JAMA
, vol.284
, pp. 1689-1695
-
-
McLellan, AT1
Lewis, DC2
O’Brien, CP3
Kleber, HD.4
-
12
-
-
85122732892
-
-
Centers for Disease Control and Prevention. Retrieved March 17, 2017
-
Centers for Disease Control and Prevention. Opioid Basics. Injury Prevention & Control: Opioid Overdose. Available at: https://www.cdc.gov/drugoverdose/opioids/index.html. Retrieved March 17, 2017.
-
Opioid Basics. Injury Prevention & Control: Opioid Overdose
-
-
-
14
-
-
60749103450
-
Motivational interviewing: a tool for behavior change. ACOG Committee Opinion No. 423. American College of Obstetricians and Gynecologists
-
Motivational interviewing: a tool for behavior change. ACOG Committee Opinion No. 423. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:243–6.
-
(2009)
Obstet Gynecol
, vol.113
, pp. 243-246
-
-
-
15
-
-
84929883760
-
Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Committee Opinion No. 633. American College of Obstetricians and Gynecologists
-
Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Committee Opinion No. 633. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1529–37.
-
(2015)
Obstet Gynecol
, vol.125
, pp. 1529-1537
-
-
-
16
-
-
78650793733
-
Substance abuse reporting and pregnancy: the role of the obstetrician–gynecologist. Committee Opinion No. 473. American College of Obstetricians and Gynecologists
-
Substance abuse reporting and pregnancy: the role of the obstetrician–gynecologist. Committee Opinion No. 473. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:200–1.
-
(2011)
Obstet Gynecol
, vol.117
, pp. 200-201
-
-
-
17
-
-
84979887646
-
Treatment of opioid-use disorders
-
Schuckit MA. Treatment of opioid-use disorders. N Engl J Med 2016;375:357–68.
-
(2016)
N Engl J Med
, vol.375
, pp. 357-368
-
-
Schuckit, MA.1
-
18
-
-
85119420901
-
-
Retrieved March 8, 2017
-
National Institute on Drug Abuse. What is heroin and how is it used? Available at: https://www.drugabuse.gov/publications/research-reports/heroin/what-heroin. Retrieved March 8, 2017.
-
What is heroin and how is it used?
-
-
-
19
-
-
85122728447
-
-
Retrieved March 8, 2017
-
National Institute on Drug Abuse. Commonly abused drug charts. Available at: https://www.drugabuse.gov/drugsabuse/commonly-abused-drugs-charts. Retrieved March 8, 2017.
-
Commonly abused drug charts
-
-
-
20
-
-
84978115719
-
Sharing of snorting straws and hepatitis C virus infection in pregnant women
-
Fernandez N, Towers CV, Wolfe L, Hennessy MD, Weitz B, Porter S. Sharing of snorting straws and hepatitis C virus infection in pregnant women. Obstet Gynecol 2016; 128:234–7.
-
(2016)
Obstet Gynecol
, vol.128
, pp. 234-237
-
-
Fernandez, N1
Towers, CV2
Wolfe, L3
Hennessy, MD4
Weitz, B5
Porter, S.6
-
21
-
-
0019453115
-
Exposure to prescribed drugs in pregnancy and association with congenital malformations
-
Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981;58:336–44.
-
(1981)
Obstet Gynecol
, vol.58
, pp. 336-344
-
-
Bracken, MB1
Holford, TR.2
-
22
-
-
84944371782
-
First-trimester drug use and congenital disorders
-
Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First-trimester drug use and congenital disorders. JAMA 1981;246:343–6.
-
(1981)
JAMA
, vol.246
, pp. 343-346
-
-
Jick, H1
Holmes, LB2
Hunter, JR3
Madsen, S4
Stergachis, A.5
-
24
-
-
0021886437
-
Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy
-
Zierler S, Rothman KJ. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 1985;313:347–52.
-
(1985)
N Engl J Med
, vol.313
, pp. 347-352
-
-
Zierler, S1
Rothman, KJ.2
-
25
-
-
79953289743
-
Maternal treatment with opioid analgesics and risk for birth defects. National Birth Defects Prevention Study
-
314.e1–11
-
Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, et al. Maternal treatment with opioid analgesics and risk for birth defects. National Birth Defects Prevention Study. Am J Obstet Gynecol 2011;204:314.e1–11.
-
(2011)
Am J Obstet Gynecol
, vol.204
-
-
Broussard, CS1
Rasmussen, SA2
Reefhuis, J3
Friedman, JM4
Jann, MW5
Riehle-Colarusso, T6
-
26
-
-
0026924498
-
Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy
-
Shaw GM, Malcoe LH, Swan SH, Cummins SK, Schulman J. Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy. Eur J Epidemiol 1992;8:757–60.
-
(1992)
Eur J Epidemiol
, vol.8
, pp. 757-760
-
-
Shaw, GM1
Malcoe, LH2
Swan, SH3
Cummins, SK4
Schulman, J.5
-
27
-
-
82455167936
-
Effects of codeine on pregnancy outcome: results from a large population-based cohort study
-
Nezvalova-Henriksen K, Spigset O, Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol 2011;67:1253–61.
-
(2011)
Eur J Clin Pharmacol
, vol.67
, pp. 1253-1261
-
-
Nezvalova-Henriksen, K1
Spigset, O2
Nordeng, H.3
-
28
-
-
84889773066
-
Periconceptional use of opioids and the risk of neural tube defects
-
Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol 2013;122:838–44.
-
(2013)
Obstet Gynecol
, vol.122
, pp. 838-844
-
-
Yazdy, MM1
Mitchell, AA2
Tinker, SC3
Parker, SE4
Werler, MM.5
-
29
-
-
84978932704
-
Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child
-
Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction 2016;111:2115–28.
-
(2016)
Addiction
, vol.111
, pp. 2115-2128
-
-
Zedler, BK1
Mann, AL2
Kim, MM3
Amick, HR4
Joyce, AR5
Murrelle, EL6
-
31
-
-
84867359892
-
Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression
-
Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse 2012;38:575–9.
-
(2012)
Am J Drug Alcohol Abuse
, vol.38
, pp. 575-579
-
-
Holbrook, A1
Kaltenbach, K.2
-
32
-
-
77952296363
-
Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples
-
Jones HE, Heil SH, O’Grady KE, Martin PR, Kaltenbach K, Coyle MG, et al. Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse 2009;35:375–80.
-
(2009)
Am J Drug Alcohol Abuse
, vol.35
, pp. 375-380
-
-
Jones, HE1
Heil, SH2
O’Grady, KE3
Martin, PR4
Kaltenbach, K5
Coyle, MG6
-
33
-
-
84994472158
-
The role of screening, brief intervention, and referral to treatment in the perinatal period
-
Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol 2016;215:539–47.
-
(2016)
Am J Obstet Gynecol
, vol.215
, pp. 539-547
-
-
Wright, TE1
Terplan, M2
Ondersma, SJ3
Boyce, C4
Yonkers, K5
Chang, G6
-
35
-
-
80052772826
-
Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification
-
Chang G, Orav EJ, Jones JA, Buynitsky T, Gonzalez S, Wilkins-Haug L. Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification. J Addict Med 2011;5:221–6.
-
(2011)
J Addict Med
, vol.5
, pp. 221-226
-
-
Chang, G1
Orav, EJ2
Jones, JA3
Buynitsky, T4
Gonzalez, S5
Wilkins-Haug, L.6
-
36
-
-
84899969107
-
-
Retrieved March 8, 2017
-
National Institute on Drug Abuse. Resource guide: screening for drug use in general medical settings. Available at: https://www.drugabuse.gov/publications/resource-guidescreening-drug-use-in-general-medical-settings/nidaquick-screen. Retrieved March 8, 2017.
-
Resource guide: screening for drug use in general medical settings
-
-
-
37
-
-
84924561739
-
Universal maternal drug testing in a high-prevalence region of prescription opiate abuse
-
Wexelblatt SL, Ward LP, Torok K, Tisdale E, Meinzen-Derr JK, Greenberg JM. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. J Pediatr 2015;166:582–6.
-
(2015)
J Pediatr
, vol.166
, pp. 582-586
-
-
Wexelblatt, SL1
Ward, LP2
Torok, K3
Tisdale, E4
Meinzen-Derr, JK5
Greenberg, JM.6
-
38
-
-
85018251177
-
-
HHS Publicatio (SMA) 16-4978. Rockville (MD): SAMHSA; Retrieved March 8, 2017
-
Substance Abuse and Mental Health Services Administration. A collaborative approach to the treatment of pregnant women with opioid use disorders. HHS Publication No. (SMA) 16-4978. Rockville (MD): SAMHSA; 2016. Available at: https://ncsacw.samhsa.gov/files/Collaborative_Approach_508.pdf. Retrieved March 8, 2017.
-
(2016)
A collaborative approach to the treatment of pregnant women with opioid use disorders
-
-
-
39
-
-
49249099427
-
Treatment of opioid-dependent pregnant women: clinical and research issues
-
Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008;35:245–59.
-
(2008)
J Subst Abuse Treat
, vol.35
, pp. 245-259
-
-
Jones, HE1
Martin, PR2
Heil, SH3
Kaltenbach, K4
Selby, P5
Coyle, MG6
-
41
-
-
85007562857
-
-
Retrieved March 8, 2017
-
Substance Abuse and Mental Health Services Administration. Opioid treatment program directory. Available at: http://dpt2.samhsa.gov/treatment/directory. aspx. Retrieved March 8, 2017.
-
Opioid treatment program directory
-
-
-
42
-
-
0021801346
-
Altered methadone pharmacokinetics in methadone-maintained pregnant women
-
Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985;233:1–6.
-
(1985)
J Pharmacol Exp Ther
, vol.233
, pp. 1-6
-
-
Pond, SM1
Kreek, MJ2
Tong, TG3
Raghunath, J4
Benowitz, NL.5
-
43
-
-
84945128652
-
The effect of methadone dose regimen on neonatal abstinence syndrome
-
McCarthy JJ, Leamon MH, Willits NH, Salo R. The effect of methadone dose regimen on neonatal abstinence syndrome. J Addict Med 2015;9:105–10.
-
(2015)
J Addict Med
, vol.9
, pp. 105-110
-
-
McCarthy, JJ1
Leamon, MH2
Willits, NH3
Salo, R.4
-
44
-
-
78249244484
-
Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis
-
Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010;105:2071–84.
-
(2010)
Addiction
, vol.105
, pp. 2071-2084
-
-
Cleary, BJ1
Donnelly, J2
Strawbridge, J3
Gallagher, PJ4
Fahey, T5
Clarke, M6
-
46
-
-
85122768769
-
Drug addiction treatment act of 2000, Pub. L. No. 106-310 § 3502
-
Retrieved March 8, 2017
-
Drug addiction treatment act of 2000, Pub. L. No. 106-310 § 3502, 114 Stat. 1223–7. (2000). Available at: https://www.gpo.gov/fdsys/pkg/PLAW-106publ310/pdf/PLAW106publ310.pdf. Retrieved March 8, 2017.
-
(2000)
Stat
, vol.114
, pp. 1223-1227
-
-
-
47
-
-
0042360208
-
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. Buprenorphine/Naloxone Collaborative Study Group
-
Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. Buprenorphine/Naloxone Collaborative Study Group. N Engl J Med 2003;349:949–58.
-
(2003)
N Engl J Med
, vol.349
, pp. 949-958
-
-
Fudala, PJ1
Bridge, TP2
Herbert, S3
Williford, WO4
Chiang, CN5
Jones, K6
-
48
-
-
84900801607
-
Buprenorphine and methadone for opioid addiction during pregnancy
-
Mozurkewich EL, Rayburn WF. Buprenorphine and methadone for opioid addiction during pregnancy. Obstet Gynecol Clin North Am 2014;41:241–53.
-
(2014)
Obstet Gynecol Clin North Am
, vol.41
, pp. 241-253
-
-
Mozurkewich, EL1
Rayburn, WF.2
-
49
-
-
85095976190
-
Maintenance agonist treatments for opiate-dependent pregnant women
-
Art
-
Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD006318.
-
(2013)
Cochrane Database of Systematic Reviews
, Issue.12
, pp. CD006318
-
-
Minozzi, S1
Amato, L2
Bellisario, C3
Ferri, M4
Davoli, M.5
-
50
-
-
0038664367
-
Use of buprenorphine in pregnancy: patient management and effects on the neonate
-
Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003;70:S87–101.
-
(2003)
Drug Alcohol Depend
, vol.70
, pp. S87-101
-
-
Johnson, RE1
Jones, HE2
Fischer, G.3
-
51
-
-
85027954995
-
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data
-
Debelak K, Morrone WR, O’Grady KE, Jones HE. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict 2013;22:252–4.
-
(2013)
Am J Addict
, vol.22
, pp. 252-254
-
-
Debelak, K1
Morrone, WR2
O’Grady, KE3
Jones, HE.4
-
52
-
-
84922437812
-
Buprenorphine and naloxone compared with methadone treatment in pregnancy
-
Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol 2015; 125:363–8.
-
(2015)
Obstet Gynecol
, vol.125
, pp. 363-368
-
-
Wiegand, SL1
Stringer, EM2
Stuebe, AM3
Jones, H4
Seashore, C5
Thorp, J.6
-
53
-
-
84943665426
-
-
Retrieved March 8, 2017
-
Substance Abuse and Mental Health Services Administration. Medication-assisted treatment: physician and program data. Available at: https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/ physician-program-data. Retrieved March 8, 2017.
-
Medication-assisted treatment: physician and program data
-
-
-
54
-
-
84855163810
-
Management of women treated with buprenorphine during pregnancy
-
Alto WA, O’Connor AB. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol 2011;205:302–8.
-
(2011)
Am J Obstet Gynecol
, vol.205
, pp. 302-308
-
-
Alto, WA1
O’Connor, AB.2
-
55
-
-
51149115082
-
Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes
-
Jones HE, O’Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008;17:372–86.
-
(2008)
Am J Addict
, vol.17
, pp. 372-386
-
-
Jones, HE1
O’Grady, KE2
Malfi, D3
Tuten, M.4
-
56
-
-
85020485840
-
Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal–Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop
-
Reddy UM, Davis JM, Ren Z, Greene MF. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal–Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop. Obstet Gynecol 2017;130:10–28.
-
(2017)
Obstet Gynecol
, vol.130
, pp. 10-28
-
-
Reddy, UM1
Davis, JM2
Ren, Z3
Greene, MF.4
-
57
-
-
85015878238
-
Medically assisted withdrawal (detoxification): considering the mother–infant dyad
-
Jones HE, Terplan M, Meyer M. Medically assisted withdrawal (detoxification): considering the mother–infant dyad. J Addict Med 2017;11:90–2.
-
(2017)
J Addict Med
, vol.11
, pp. 90-92
-
-
Jones, HE1
Terplan, M2
Meyer, M.3
-
58
-
-
85021001433
-
Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment
-
Saia KA, Schiff D, Wachman EM, Mehta P, Vilkins A, Sia M, et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Curr Obstet Gynecol Rep 2016;5:257–63 .
-
(2016)
Curr Obstet Gynecol Rep
, vol.5
, pp. 257-263
-
-
Saia, KA1
Schiff, D2
Wachman, EM3
Mehta, P4
Vilkins, A5
Sia, M6
-
59
-
-
0015781506
-
Narcotic withdrawal in pregnancy: stillbirth incidence with a case report
-
Rementeria JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol 1973;116:1152–6.
-
(1973)
Am J Obstet Gynecol
, vol.116
, pp. 1152-1156
-
-
Rementeria, JL1
Nunag, NN.2
-
60
-
-
0016785589
-
Fetal stress from methadone withdrawal
-
Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43–6.
-
(1975)
Am J Obstet Gynecol
, vol.122
, pp. 43-46
-
-
Zuspan, FP1
Gumpel, JA2
Mejia-Zelaya, A3
Madden, J4
Davis, R.5
-
61
-
-
0038350387
-
Is opiate detoxification unsafe in pregnancy?
-
Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 2003;24:363–7.
-
(2003)
J Subst Abuse Treat
, vol.24
, pp. 363-367
-
-
Luty, J1
Nikolaou, V2
Bearn, J.3
-
62
-
-
84964671778
-
Detoxification from opiate drugs during pregnancy
-
374.e1–6
-
Bell J, Towers CV, Hennessy MD, Heitzman C, Smith B, Chattin K. Detoxification from opiate drugs during pregnancy. Am J Obstet Gynecol 2016;215:374.e1–6.
-
(2016)
Am J Obstet Gynecol
, vol.215
-
-
Bell, J1
Towers, CV2
Hennessy, MD3
Heitzman, C4
Smith, B5
Chattin, K.6
-
63
-
-
84929672087
-
Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996–2009
-
Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarko L, et al. Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996–2009. Eur Addict Res 2015;21:253–61.
-
(2015)
Eur Addict Res
, vol.21
, pp. 253-261
-
-
Welle-Strand, GK1
Skurtveit, S2
Tanum, L3
Waal, H4
Bakstad, B5
Bjarko, L6
-
64
-
-
84872512579
-
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research
-
Jones HE, Chisolm MS, Jansson LM, Terplan M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction 2013;108:233–47.
-
(2013)
Addiction
, vol.108
, pp. 233-247
-
-
Jones, HE1
Chisolm, MS2
Jansson, LM3
Terplan, M.4
-
65
-
-
84859862167
-
Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: an initial survey
-
Jones HE. Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: an initial survey. Am J Addict 2012;21:199–201.
-
(2012)
Am J Addict
, vol.21
, pp. 199-201
-
-
Jones, HE.1
-
66
-
-
84928946399
-
-
Rockville (MD): SAMHSA; Retrieved March 8, 2017
-
SubstanceAbuseandMentalHealthServicesAdministration. SAMHSA opioid overdose prevention toolkit. Rockville (MD): SAMHSA; 2016. Available at: http://store.samhsa.gov/shin/content//SMA16-4742/SMA16-4742.pdf. Retrieved March 8, 2017.
-
(2016)
SAMHSA opioid overdose prevention toolkit
-
-
-
67
-
-
84955445497
-
Optimizing support for breastfeeding as part of obstetric practice. Committee Opinion No. 658. American College of Obstetricians and Gynecologists
-
Optimizing support for breastfeeding as part of obstetric practice. Committee Opinion No. 658. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e86–92.
-
(2016)
Obstet Gynecol
, vol.127
, pp. e86-e92
-
-
-
68
-
-
34548445943
-
Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy
-
Meyer M, Wagner K, Benvenuto A, Plante D, Howard D. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol 2007;110:261–6.
-
(2007)
Obstet Gynecol
, vol.110
, pp. 261-266
-
-
Meyer, M1
Wagner, K2
Benvenuto, A3
Plante, D4
Howard, D.5
-
69
-
-
68249148032
-
Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy
-
Jones HE, O’Grady K, Dahne J, Johnson R, Lemoine L, Milio L, et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse 2009;35:151-6.
-
(2009)
Am J Drug Alcohol Abuse
, vol.35
, pp. 151-156
-
-
Jones, HE1
O’Grady, K2
Dahne, J3
Johnson, R4
Lemoine, L5
Milio, L6
-
70
-
-
33646505796
-
Post-cesarean pain management of patients maintained on methadone or buprenorphine
-
Jones HE, Johnson RE, Milio L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict 2006;15:258–9.
-
(2006)
Am J Addict
, vol.15
, pp. 258-259
-
-
Jones, HE1
Johnson, RE2
Milio, L.3
-
71
-
-
85021856551
-
Obstetric analgesia and anesthesia. ACOG Practice Bulletin No. 177. American College of Obstetricians and Gynecologists
-
Obstetric analgesia and anesthesia. ACOG Practice Bulletin No. 177. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e73–89.
-
(2017)
Obstet Gynecol
, vol.129
, pp. e73-e89
-
-
-
73
-
-
0030695885
-
Methadone distribution and excretion into breast milk of clients in a methadone maintenance pro-gramme
-
Wojnar-Horton RE, Kristensen JH, Yapp P, Ilett KF, Dusci LJ, Hackett LP. Methadone distribution and excretion into breast milk of clients in a methadone maintenance pro-gramme. Br J Clin Pharmacol 1997;44:543–7.
-
(1997)
Br J Clin Pharmacol
, vol.44
, pp. 543-547
-
-
Wojnar-Horton, RE1
Kristensen, JH2
Yapp, P3
Ilett, KF4
Dusci, LJ5
Hackett, LP.6
-
74
-
-
84926457658
-
ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015
-
Reece-Stremtan S, Marinelli KA. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med 2015;10: 135–41.
-
(2015)
Breastfeed Med
, vol.10
, pp. 135-141
-
-
Reece-Stremtan, S1
Marinelli, KA.2
-
75
-
-
84884583901
-
The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Committee on Drugs
-
Sachs HC. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Committee on Drugs. Pediatrics 2013;132:e796–809.
-
(2013)
Pediatrics
, vol.132
, pp. e796-e809
-
-
Sachs, HC.1
-
77
-
-
70349251864
-
Dosing adjustments in postpartum patients maintained on buprenorphine or methadone
-
Jones HE, Johnson RE, O’Grady KE, Jasinski DR, Tuten M, Milio L. Dosing adjustments in postpartum patients maintained on buprenorphine or methadone. J Addict Med 2008;2:103–7.
-
(2008)
J Addict Med
, vol.2
, pp. 103-107
-
-
Jones, HE1
Johnson, RE2
O’Grady, KE3
Jasinski, DR4
Tuten, M5
Milio, L.6
-
78
-
-
84897431634
-
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers
-
Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L, et al. Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers. Am J Obstet Gynecol 2014;210:302–10.
-
(2014)
Am J Obstet Gynecol
, vol.210
, pp. 302-310
-
-
Jones, HE1
Deppen, K2
Hudak, ML3
Leffert, L4
McClelland, C5
Sahin, L6
-
79
-
-
84900565585
-
Prenatal and postpartum care of women with substance use disorders
-
Gopman S. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin North Am 2014;41:213–28.
-
(2014)
Obstet Gynecol Clin North Am
, vol.41
, pp. 213-228
-
-
Gopman, S.1
-
80
-
-
84937569544
-
Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecologists
-
Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1268–71.
-
(2015)
Obstet Gynecol
, vol.125
, pp. 1268-1271
-
-
-
81
-
-
0035372575
-
Buprenorphine treatment of pregnant opioid—dependent women: maternal and neonatal outcomes
-
Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM, et al. Buprenorphine treatment of pregnant opioid—dependent women: maternal and neonatal outcomes. Drug Alcohol Depend 2001;63:97–103.
-
(2001)
Drug Alcohol Depend
, vol.63
, pp. 97-103
-
-
Johnson, RE1
Jones, HE2
Jasinski, DR3
Svikis, DS4
Haug, NA5
Jansson, LM6
-
82
-
-
85065040257
-
-
Chevy Chase (MD): ASAM; Retrieved March 8, 2017
-
American Society of Addiction Medicine. Public policy statement on the use of naloxone for the prevention of opioid overdose deaths. Chevy Chase (MD): ASAM; 2016. Available at: http://www.asam.org/docs/defaultsource/public-policy-statements/use-of-naloxone-for-theprevention-of-opioid-overdose-deaths-final.pdf?sfvrsn=4. Retrieved March 8, 2017.
-
(2016)
Public policy statement on the use of naloxone for the prevention of opioid overdose deaths
-
-
-
83
-
-
84942552331
-
Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review
-
Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med 2015;80:23–31.
-
(2015)
Prev Med
, vol.80
, pp. 23-31
-
-
Terplan, M1
Hand, DJ2
Hutchinson, M3
Salisbury-Afshar, E4
Heil, SH.5
-
84
-
-
85047588413
-
Immediate postpartum long-acting reversible contraception. Committee Opinion No. 670. American College of Obstetricians and Gynecologists
-
Immediate postpartum long-acting reversible contraception. Committee Opinion No. 670. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e32–7.
-
(2016)
Obstet Gynecol
, vol.128
, pp. e32-e37
-
-
-
85
-
-
84859887561
-
Methadone and buprenorphine for the management of opioid dependence in pregnancy
-
Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012;72:747–57.
-
(2012)
Drugs
, vol.72
, pp. 747-757
-
-
Jones, HE1
Finnegan, LP2
Kaltenbach, K.3
-
86
-
-
85122766610
-
-
Retrieved March 8, 2017
-
Ohio Perinatal Quality Collaborative. Neonatal abstinence syndrome and maternal addiction. Available at: https://opqc.net/patients-providers/%20NAS. Retrieved March 8, 2017.
-
Neonatal abstinence syndrome and maternal addiction
-
-
-
87
-
-
84873405416
-
Neonatal abstinence syndrome: treatment and pediatric outcomes
-
Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol 2013;56:186–92.
-
(2013)
Clin Obstet Gynecol
, vol.56
, pp. 186-192
-
-
Logan, BA1
Brown, MS2
Hayes, MJ.3
-
88
-
-
0021691269
-
Developmental outcome of children born to methadone maintained women: a review of longitudinal studies
-
Kaltenbach K, Finnegan LP. Developmental outcome of children born to methadone maintained women: a review of longitudinal studies. Neurobehav Toxicol Teratol 1984;6:271–5.
-
(1984)
Neurobehav Toxicol Teratol
, vol.6
, pp. 271-275
-
-
Kaltenbach, K1
Finnegan, LP.2
-
89
-
-
0024336127
-
Developmental consequences of prenatal exposure to methadone
-
Hans SL. Developmental consequences of prenatal exposure to methadone. Ann N Y Acad Sci 1989;562:195–207.
-
(1989)
Ann N Y Acad Sci
, vol.562
, pp. 195-207
-
-
Hans, SL.1
|